Quick Answer
Cytosorbents Corp reported Gross Profit of $26.49 million for the year ending 2025.
- Cytosorbents Corp showed an increase of +6.4% in Gross Profit from 2024 to 2025.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $990.7 thousand | Q2 2016: $1.35 million | Q3 2016: $1.45 million | Q4 2016: $1.79 million | Q1 2017: $1.86 million | Q2 2017: $2.08 million | Q3 2017: $2.31 million | Q4 2017: $3.38 million | Q1 2018: $3.36 million | Q2 2018: $3.97 million | Q3 2018: $3.69 million | Q4 2018: $4.00 million | Q1 2019: $3.45 million | Q2 2019: $4.40 million | Q3 2019: $4.40 million | Q4 2019: $5.34 million | Q1 2020: $6.32 million | Q2 2020: $6.55 million | Q3 2020: $7.66 million | Q4 2020: $9.43 million | Q1 2021: $7.85 million | Q2 2021: $9.31 million | Q3 2021: $7.30 million | Q4 2021: $7.66 million | Q1 2022: $6.41 million | Q2 2022: $4.94 million | Q3 2022: $3.62 million | Q4 2022: $5.76 million | Q1 2023: $5.46 million | Q2 2023: $6.02 million | Q3 2023: $5.61 million | Q4 2023: $5.31 million | Q1 2024: $6.87 million | Q2 2024: $6.50 million | Q3 2024: $5.26 million | Q1 2025: $6.21 million | Q2 2025: $6.81 million | Q3 2025: $6.67 million.
- Over the full 15 years of available data (2011 to 2025), Cytosorbents Corp's Gross Profit has grown by 108,835.8%.
- Historical annual values: Fiscal year 2025: $26.49 million | Fiscal year 2024: $24.89 million | Fiscal year 2023: $21.95 million | Fiscal year 2022: $20.73 million | Fiscal year 2021: $32.12 million | Fiscal year 2020: $29.95 million | Fiscal year 2019: $17.59 million | Fiscal year 2018: $15.01 million | Fiscal year 2017: $9.63 million | Fiscal year 2016: $5.57 million | Fiscal year 2015: $2.58 million | Fiscal year 2014: $1.99 million | Fiscal year 2013: $511.1 thousand | Fiscal year 2012: $1.02 million | Fiscal year 2011: $24.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: